Drugmakers Must Stop Their Pricing Games
By Art Wingerter Drug spending in the U.S. approached $300 billion in 2014, up by more than $30 billion over the previous year. That jump in spending didn’t go unnoticed. Seventy-seven percent of respondents to a recent...
Read More
